Clinical use of telemonitoring in chronic heart failure: Keeping up with the times or misuse of time?

Current Heart Failure Reports

Volumn 9, Issue 1, 2012, Pages 75-80

  Stoyanov, Nik ^a   Paul, Vince ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Cardiac resynchronization therapy; Heart failure; Hospitalization; Impedance; Implantable defibrillator; Nonpharmacologic therapy; Pressure monitor; Remote monitoring; Telemonitoring

Indexed keywords

CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CLINICAL PRACTICE; DEFIBRILLATOR; FOLLOW UP; HEART FAILURE; HEART HEMODYNAMICS; HEMODYNAMIC MONITORING; HOSPITALIZATION; HUMAN; LIFESTYLE MODIFICATION; MORTALITY; PACEMAKER; PATIENT COMPLIANCE; PHARMACEUTICAL CARE; REVIEW; RISK REDUCTION; TELEMONITORING;

CHRONIC DISEASE; ELECTRODES, IMPLANTED; HEART FAILURE; HUMANS; MONITORING, AMBULATORY; TELEMEDICINE; TELEPHONE;

EID: 84862882749     PISSN: 15469530     EISSN: 15469549     Source Type: Journal    
DOI: 10.1007/s11897-011-0074-4     Document Type: Review

References (30)

1. Fonarow GC, Stevenson LW, Walden JA, et al. Impact of comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure. J Am Coll Cardiol. 1997;30(3):725.
2. Hunt SA, Abraham WT, Chin MH, et al. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the diagnosis and management of heart failure in adults. Circulation. 2009;119:e391.
3. Solomon SD, Dobson J, Pocock S, et al. Candesartan in Heart Failure: Assessment of reduction in mortality and morbidity (CHARM) investigators. Circulation. 2007;116(13):1482.
4. GESICA Investigators. Randomised trial of telephone intervention in chronic heart failure: DIAL trial. BMJ. 2005;331:425.
5. Clark RA, Inglis SC, McAlister FA, et al. Tele-monitoring or structured telephone support programmes for patients with chronic heart failure: systematic review and meta-analysis. BMJ. 2007;334:942.
6. Inglis SC, Clark RA, McAlister FA, et al.: Structured telephone support or telemonitoring programmes for patients with chronic heart failure (Review). Cochrane Collaboration, The Cochrane Library 2010, Issue 8.
7. Klersy C, De Silvestri A, Gabutti G, et al.: A meta-analysis of remote monitoring of heart failure patients. J. Am. Coll. Cardiol. 2009;54;1683-1694.
8. Goldberg LR, Piette JD, Walsh MN, et al. A daily electronic home monitoring system in patients with advanced heart failure improves survival: the WHARF (weight monitoring in heart failure) trial. J Card Fail. 2002;8:S54.
9. Cleland JG, Louis AA, Rigby AS, et al. Noninvasive home monitoring for patients with heart failure at high risk of recurren admission and death: The Ten-HMS Study. Heart Failure. 2005;45:10.
10. Koehler F, Winkler S, Schiever M, et al.: Telemedical Intervnetional Monitoring in Heart Failure (TIM-HF), a random-izd, controlled inervention trial investigating the impact of telemedicine on mortality in ambulatory patients with heart failure: study design. European Journal of Heart Failure (2010) 12, 1354-1362.
11. Chaudhry SI, Mattera JA, Curtis JP, et al.: Telemonitoring in Patients with Heart Failure. N Engl J Med 2010;363:2301-9.
12. HRS/EHRA Expert consensus on the monitoring of cardiovascular implantable electronic devices. Description of techniques, indications, personnel, frequency and ethical considerations. Europace. 2008;10:707-25.
13. Crossley GH, Boyle A, Vitense H, et al. The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) Trial: The value of wireless remote monitoring with automatic clinician alerts. JACC. 2011;57:1181-9.
14. Dries DL, Exner DV, Gersch BJ. Atrial fibrillation is associated with increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular dysfunction. J Am Coll Cardiol. 1998;S32:695-703. (Pubitemid 28435256)
15. Madsen BK, Hansen JF, Stokholm KH, et al. Chronic congestive cardiac failure. Description and survival of 190 consecutive patients with a diagnosis of chronic congestive cardiac failure based on clinical signs and symptoms. Eur Heart J. 1994;15:304-6.
16. Ellery S, Pakrashi T, Paul V, Sack S. Predicting mortality and rehospitalisation in heart failure patients with home monitoring-the Home CARE pilot study. Clin Res Cardiol. 2006;95 Suppl 3: III29-35.
17. La Rovere MT, Pinna GD, Maestri R, et al. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation. 2003;107:565-70. (Pubitemid 36176805)
18. Adamson PB, Smith AL, Abraham WT, et al.: Continuous Autonomic Assessment in Patients With Symptomatic Heart Failure: Prognostic Value of Heart Rate Variability Measured by an Implanted Cardiac Resynchronization Device Circulation 2004; 110:2389-2394. (Pubitemid 39407344)
19. Ewald GA, Gilliam FR, Sweeney RJ. Automated HF Decompensation Detection: Results from the Decompensation Detection Study (DECODE). J Card Fail. 2009;15:S122.
20. Abraham WT. Intrathoracic impedance monitoring for early detection of heart failure decompensation. CHF. 2007;13:113-5.
21. Yu CM, Wang L, Chau E, et al.: Intrathoracic Impedance Monitoring in Patients With Heart Failure: Correlation With Fluid Status and Feasibility of Early Warning Preceding Hospitalization Circulation 2005;112:841-848 (Pubitemid 41170070)
22. Abraham WT, Compton S, Haas G, et al.: Superior performance of intrathoracic impedence-derived fluid index versus daily weight monitoring in heart failure patients: Results of the fluid accumulation status trial (FAST). J Cardiac Fail 2009; 15: 9,813
23. Ypenburg C, Bax JJ, Van Der Wall EE, et al. In-trathoracic impedance monitoring to predict decompensated heart failure. Am J Cardiol. 2007;99:554-7. (Pubitemid 46215562)
24. Catanzariti D, Lunati M, Landolina M, et al.: Monitoring intrathoracic impedance with an implantable defibrillator reduces hospitalizations in patients with heart failure. PACE 2009; 32:363-370.
25. Whellan D, Ousdigian KT, Al-Khatib SM, et al. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalization. J Am Coll Cardiol. 2010;55:1803-10.
26. http://clinicaltrials.gov/ct2/show/NCT00480077
27. http://clinicaltrials.gov/ct2/show/NCT00510198
28. Brachmann J, Bohm M, Rybak K, et al. Fluid status monitoring with a wireless network to reduce cardiovascular-related hospitalizations and mortality in heart failure: rationale and design of the OptiLin HF Study (Optimization of Heart Failure Management using OptiVol Fluid Status Monitoring and CareLink). Eur J Hear Fail. 2011;13:796-804.
29. Bourge RC, Abraham WT, Adamson PB, et al. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: The COMPASS-HF Study. J Am Coll Cardiol. 2008;51:1073-9. (Pubitemid 351374766)
30. Abraham WT, Adamson PB; CHAMPION Trial Committees and Study Group: Primary Results of the CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Heart Failure Patients (CHAMPION) Trial [abstract]. European Society of Cardiology Heart Failure Congress 2010, Berlin, Germany.